However, whether improper NF-κB activation may contribute to metabolic disease and aging in part through dysregulation of circadian systems remains an important question to be explored, particularly in regard to the determination of which neuronal cell types are influenced by NF-κB signaling in the brain. The gene discussed is NFKB1; the disease is metabolic disease.